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Abstract 
Today, tea is an important source ofbeverage. However Chinese also like to mix 
different plants to make herbal tea for drinking even in the presence of Chinese 
Camellia tea. One of them is Kudingcha, suggesting that Kudingcha may have some 
medicinal benefits, such as hypolipidemic effect. Ilex latifolia (DL) is a Kudingcha, 
which is rich in saponins. Saponins exert many different biological activities such as 
anti-allergic activities. Therefore it was worthy to study the medicinal effects of JL 
extract and a saponin-enriched fraction (SEF) obtained from EL 
In a toxicity study, JL and SEF did not produce liver cell damage after 
administration for one day and for two weeks. JL and SEF did not induce MROD and 
EROD activity. Besides SEF had no effect on GST activity either. However TL 
induced GST activity after administration for one day and two weeks. It appeared 
that the components in E. for induction of GST activity may not be the saponins. 
Li a study on the hypoglycemic effect, both EL and SEF reduced the serum 
glucose level in an oral glucose tolerance experiment. However no hypoglycemic 
effect was produced in streptozotocin-induced diabetic mice. It is possible that the 
hypoglycemic effect of EL. and SEF is due to a reduced intestinal absorption of 
glucose. Repeated administrations ofR. and SEF reduced the serum glucose level in 
streptozotocin-induced diabetic mice, suggesting th^t the hypoglycemic effect of IL 
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and SEF may be due to an enhancement of glucose utilization besides a reduction in 
glucose adsorption. 
Both JL and SEF reduced serum cholesterol and triglyceride levels in three sets 
ofexperiments: mice fed with a high-cholesterol emulsion, hyperlipidemic mice and 
in the diabetes-induced hyperlipidemic mice. The hypolipidemic effect of JL and 
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L1 History ofTea 
There is no actual written history supporting the many legends and stories 
regarding tea's discovery and subsequent development. There were two major 
legends and it is safe to conclude that the events depicted in the second one may 
actually be closer to the true events. Emperor Shen Nung of China discovered tea in 
about 2700 B.C.. Believing that water should be boiled as a hygienic precaution, he 
discovered a new beverage when tea leaves were blown into boiling water. Being 
scientifically minded, he tested this new brew and found it refreshing. The second 
legend is placed in the later Han dynasty, somewhere around 25-221 A.D., where it is 
mentioned that when Gan Lu returned from his Buddhist studies in India, he brought 
back tea plants which he then planted in the Meng mountains, in the district of 
Szechwan. However, the first credible mention was by Liu Kun, a general of the 
Ching dynasty in the fourth century A.D. who wrote to his nephew，the governor of 
Yenchow in Shantung province, saying ”. . . that he felt aged and depressed and 
wanted some real t'u" (Palmer, 1999). Then tea production had developed 
significantly with the transmission oftea seeds and the extension oftea area. More 
than a thousand year ago, China started to export tea and established trade 
relationships with over 30 countries in the Middle East, Southeast Asia, West Europe 
and East Europe (Chen and Lu，1993). 
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1,2 Tea consumption in the world 
Today, tea is an important source ofbeverage. In 1994，2½ million metric tons 
of tea was produced worldwide. Some of this tea is retained by the producing 
countries for internal consumption, while the rest is traded either directly to value-
added resellers in other countries or bought through auction on the open market. 
Green tea is consumed primary in China, Japan，and some parts ofthe Middle East 
and North Africa，whereas black tea is mostly consumed in Western countries. Tea 
consumption in selected countries is summarized in Figure 1.1. 
1.3 Classification of Chinese tea 
There are numerous kinds of tea corresponding with the long history an4 vast 
tea areas in China. Chinese tea can be basically divided into six categories, i.e. green 
tea，black tea, oolong tea, white tea, yellow tea and black-black tea. The 
classification is based on the degree offermentation and oxidation of the polyphenols 
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Figure 1.1 Tea consumption in various countries. (Anonymous, 1995) 
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Table 1. l Categories of Chinese tea (Chen and Lu, 1995) 
Categories Features 
Green tea Non-fermented tea 
Black tea Fermented tea 
Oolong tea Semi-fermented tea 
White tea Light-fermented tea 
Yellow tea Non-enzymetically oxidized tea 
Black-black tea Post-fermented tea 
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1.4 Tea and health 
Tea has been known from the ancient time to possess many medicinal properties 
but evaluation of its biological activities is still in its infancy. Diverse claims like 
antidiabetic, antiallergic, antioxidative, antiulcer and antihypertensive properties of 
tea are sketchy and warrant confirmation (Ganguly, 1993). Most of these studies are 
limited to Chinese and Japanese green tea extracts containing large amounts of free 
catechins and low quantities of catechin oxides. Anticarcinogenic, antiatherosclerotic, 
antimicrobial including anticholeric and anticarious properties of green tea extracts 
and its polyphenolic constituents are scientifically validated to some extent in animal 
experiments. The results can partially reflect the beneficial effects of drinking tea. 
1.5Herbal tea 
Herbal tea arose out of the climatic conditions of southern China where 
summers are hot and humid. When people in this region suffered from illness, they 
sought cost-effective treatments, often turning to local herb-blends. They boiled local 
plants to address a range of illnesses，including viral infections，liver problems, bone 
and muscle soreness, and eye infections (Hu, 1997). 
In southern China different kinds ofhollies are used for herbal tea and medicine. 
One particular kind of bitter tea, called Kudingcha meaning literally '%itter tea，，，is 
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made of the young shoots of Ilex kudingcha (Aquifoliaceae). Other closely related 
species are also used, e.g. L latifolia (Kong et al., 1998). There are a lot of plants, 
belonging to different families and genera, which were used as its original materials 
and are shown in Table 1.2 
Kudingcha is extremely bitter as a drink of pleasure. However, connoisseurs 
still like it even in the presence ofChinese Camellia tea. It indicated that partons of 
Kudingcha must find in it some medicinal properties other than those of tea. 
Kudingcha and Chinese Holly tea contain more or less the same phytochemical 
components as Camellia tea. Both of them contain triterpene saponins，flavonoids 
and polyphenols. The beneficial effects ofKudingcha may be related to the presence 
of similar compounds in Camellia tea. The effects of drinking Kudingcha included 
diuretic, treatment for sore throat, headache and toothache, weight loss, control 
hypentension, fertility regulation and detoxification (Zhong Yao Da Ci Dian, 1977; 
But, 1985;Ouyang, 1996). 
1.6 Trilex Tea 
Trilex tea is a registered brand name owned by The Chinese University ofHong 
Kong. Its production is very different from that of Kudingcha. It is a product, 
developed by scientists at The Chinese University ofHong Kong. The aim ofthe 
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Table 1.2 The original species ofKudingcha in different areas in China 
(Zheng et al., 1992) 
Species Family Province 
Ligustrum pedunculare Oleaceae Sichuan 
Rehd 
L. purpurascends Y. C. Oleaceae Yunnan 
Yang 
L. japonicum var. Oleaceae Guizhou 
puhescens Koidz 
L. rohustum (Roxb.)Bl. Oleaceae Guizhou 
Ilex comuta Lindl. Ex. Aquifoliaceae Zhejiang 
Paxt. 
Ilex kudingcha C. J. Aquifoliaceae Guangxi 
Tseng 
Ilex latifolia Thunb. Aquifoliaceae Zhejiang, Hunan 
Cratoxylum pninifolium Guttifera Guangxi 
(Kurz) Dyer 
Ehretia thyrsiflora Ehretiacae Guangxi 
(S.etZ.)Nakai 
Photinia serruiata Lindl Rosaceae Zhejiang 
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research was to establish the scientific basis for ethnomedical use of herbal tea used 
in China (Hu, 1997，Kong and Hu, 1998). Moreover the design ofTrilex is based on 
both experiences ofthe people and by the principles ofmultiple complementary 
ingredients followed in prescription of traditional Chinese medicine. Trilex is a 
medicated tea with extracts of three hollies and five other crude drugs added to 
Camellia tea or a tea used by farmers in northern China (roasted old mulberry leaves) 
(Kong et al., 1999). Ilex latifolia ODL) is one ofthe major hollies in Trilex tea and is 
used for studying its pharmacological effects. 
L7Ilexlatifolia 
Holly is a broad-leafed evergreen shrub or tree that may have spiny or smooth 
leaves and whose berries can be red, orange, yellow or black. Most hollies are either 
female or male and in order for berries to form (with only a few exceptions), the 
female holly plant will have to have a male pollinator close by (Lynne, 1999). E., 
which is native to China and Japan, has large dull green leaves. A very large holly 
tree (slow growth to 60 feet) bears large dull red berries. The related information of 
EL and the photographs of the JL plant and its leaves are shown Figures 1.2 and 1.3. 
The district distribution ofDL covers Anhui, Fujian, Jiangsu and Zhejiang. Besides E. 
can also be found in Japan. There is little information about the chemical constituents 
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BOTANICAL NAME: Ilex latifoUa 
COMMON NAME: LusterleafHolly 
FANflLY: Aquifoliaceae 
NATIVITY: China，Japan. 
GROWTH HABIT: Pyramidal tree with dense growth. 
SraE: 50 - 60' in its native habitat，15 - 25' in cultivation. 
HARDEMESS: Zone 7 - 9. 
CULTURE: Full sun，in well-drained, moist soils. 
FOLIAGE: Alternate, oblong, with relatively finely serrate margins, 4 - 8" long. 
Foliage is leathery and course texture. Blends well with the texture and color of 
Southern magnolia foliage. 
FLOWERS: Dioecious, creamy white, quite fragrant. 
FRUIT: Dnipe, red, about 1/3” long, generally bome in abundance. 
Figure 1.2 Information about E. (Mackenzie et aI., 1999) 
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in IL. From some preliminary studies, EL contains saponins, polyphenols, amino 
acids, vitamin C and other chemicals. The chemical composition of JL is shown in 
Table 1.3. Saponin is one of the major components in IL. The medicinal effect ofDL 
may be related to the large amount of saponin present. Therefore saponin-enriched 
fraction (SEF) ofBL is worthy of investigation. 
1.8 Saponin 
Saponins are a structurally diverse group of naturally occuring compounds 
found mainly in plants. Chemically they consist of a steroid or triterpene group ( the 
aglycone) linked to one or more sugar molecules. The structure of one of the 
saponins from soya bean is shown in Figure 1.4. The molecules are thus amphiphilic， 
the triterperene or steroid part being hydrophobic and the sugar part hydrophilic. This 
gives saponins their characteristic surface activity from which the name is derived. 
The biological activity of saponin is closely related to its specific structure (Sidhu et 
al.，1986). 
l,9Saponins in food and its biological effects 
Saponins have been identified in many hundreds of plant species but only a few 
ofthem are used as food by man. Some of them and their saponin content is shown 
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Water soluble carbohydrates 6.99% 
Alkaloids 1% 
Vitamin C 0.031%-0.045% 
Amino acids 0.14% 
Special chemicals found in JL: taraxerol, ursolic acid，a-amyrin, P-amyrin, 
P-sitosterpol, latifolosides A,B,C,D and E. 
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Figure 1.4 The structure of a saponin from soya bean (Sidhu et al., 1986) 
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in Table 1.4. Most ofthe saponin-containing food plants are legumes including 
chickpeas, lentils, soy beans and peanuts. Alfalfa sprouts, which are particularly rich 
in saponins, have become popular in Australia as a salad vegetable (Oakenfull, 
1990). 
Saponins are known as natural surfactants. In addition to its physical property, 
saponins exhibit a variety of biological activities and some of them are listed below 
(Cheeke，1983): 
1. Irritation of mucous membranes 
2. Erythrocyte hemolysis 
3. Enzyme inhibition 
4. Effects on feed intake and diet palatability 
5. Effects on absorption of nutrients 
6. Effects on cholesterol and bile acid metabolism 
7. Antifungal activity 
8. Anti-allergic effects 
It indicates that saponins may have significant effects on all phases of animal 
production, from the ingestion of feed to the excretion of wastes. They also have a 
role in plants in protection against insects and disease. Alfalfa saponins protect the 
plant against numerous pathogenic fiingi, particularly in the root (Cheeke, 1983). 
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Table 1.4 Plant foods and their saponin content (Oakenfull et aI., 1990) 
Plant Saponin content (g/kg) 
Alfalfa sprouts {Medicago sativa) 80 
Chickpea {Cicer arietimim) 2.3 -60 
Soya bean {Glycine max) 5.6-56 
Navy bean {Phaseolus vulagaris) 4.5 -21 
Lentil {Lens culinaris) 1.1-5 .1 
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L10 The saponins in IL 
As mentioned before, saponin is one of the major components in JL. Different 
triterpenoid saponins can be found in IL (Ouyang, et aI., 1997; Ouyang, et al, 1998). 
Their structures are shown in Figure 1.5. 
Saponins exhibit a variety ofbiological activities and have been investigated for 
development of new natural medicines and to prove the efficacy of traditional herbal 
medicine. 
Lll Outline of the thesis 
n^ is one of major parts of trilex tea and is a kind of kudingcha. JL has been 
stated to have some medicinal benefits. Scientific evidence to support the statement 
is lacking. Besides saponins exhibit some biological activities. It is rich in JL and 
may contribute to its medicinal benefits. Therefore it is worth studying. 
In the present investigation, the toxicity and detoxification of JL and SEF were 
tested. The hypoglycemic and hypolipidemic effects of R. were also examined to 
explore its medicinal benefits. 
17 
- R1 R2 






f " ^ ^ f ^ ^ f f ^ c o o R 
^ ^ \ ^ ^ ^ ^ \ ^ RiO ,..••、 
'"''：..,。、、、、、、 2 Ara Rha Glc 
H O " 、 . . . ^ > ^ 
3 Ara Rha Glc 
r " " " V ^ ^ ^ Y ^ 
i = Glc 
f " ^ ^ ^ f " ^ f t ^ c o o F ^ 
/ ^ \ ^ / ^ v ^ 
RiO / •、 
. \ A Ara Rha Glc 
V N 、Z, 5 Ara Rha Glc 
HO、、 
^^^^^V^^N^ 
5 r Glc 
f " " f ^ ^ 4 ^ c o o B 
x^N^^^^vx^ _ 
R i �/ \ 
Figure 1.5 The structure of five triterpenoid saponins in JL. 
Latifoloside A(1), B(2), C(3), D(4) and E(5) (Ouyang et aL, 1987) 
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Z1.1 Toxicity ofherbal tea 
Mividuals who attempt to reduce their caffeine intake often consume herbal 
tea 一 "natural" beverages that enjoy a reputation as being particularly “ health 
food "products (Hiscoe, 1983). Over the past decade, however, at least 26 herbal tea 
have been found to be responsible for gastrointestinal, hepatic，hematologic and 
nervous system abnormalities (Ridker, 1987). Five ofthem are shown in Table 2.1. 
Most ofthese tea are commercially available, although exposure to toxic herbal tea 
has also followed misidentification of plant material as that cultivated at home. 
Within the United States, four fatalities have been reported from herbal tea poisoning 
(Ridker, 1987). Nowadays the growing consumption ofhealth food and exposure to 
potentially toxic herbal products can be expected to increase. Therefore toxicity tests 
of different kinds of herbal teas are of critical importance. 
ZL2 Hepatotoxicity 
The liver plays a major role in the detoxification of xenbiotics for protection. 
Some herbal teas, mentioned in Table 2.1，were suspected to cause hepatic failure by 
interfering with the detoxification process. Therefore testing the toxicity of herbal 
teas on the liver is important. Aspartate aminotransferase (AST) and alanine 
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Table 2.1 Potential toxicity ofherbal tea (Ridker，1987) 
Tea constituent Botanical source Suspected toxin Clinical toxicity 
Buckthom Hiptothae anthraquinones Cathartic toxin 
rhamnoides Severe watery 
Comfrey Symphytum Pyrrolizidine Hepatic failure 
officinale alkaloids 
Hops Humulus lupulus lupuline Intravascular 
hemolysis 
Mate Ilex paraguayensis Pyrrolizidine Hepatic failure 
alkaloids 
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aminotransferase (ALT) are two biomarkers for liver damage. Since AST and ALT 
are present at high concentrations in liver cells, damage to the liver cells will cause 
the serum AST and ALT levels to increase. Therefore, a rise in serum AST and a rise 
in serum ALT are two sensitive indicators for liver cell damage. 
2.1.3 Objectives 
The aim of this investigation was to study whether acute and sub-chronic 
treatment with JL and SEF produced any liver damage in normal mice. The effects of 
n . and SEF on various xenobiotic enzymes were also tested to study their effects on 
the liver detoxification process. 
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2^2 Materials andMethods 
2.2.1 Materials 
Sodium chloride，sodium sulphate，glucose-6-phosphate, glucose-6-phosphate 
dehydrogenase, NADP+，bovine serum albumin，hydrochloric acid, sodium 
hydroxide, magnesium sulfate, methoxyresorufin, ethoxyresorufin, l,2-dichloro-4 -
nitrobenzene, glycine, sucrose，potassium chloride, EDTA, potassium phosphate and 
oxidized glutathione were obtained from Sigma St. Louis, Missouri, U.S.A.. 
Methanol and ethanol were obtained from New England Nuclear Life Science， 
U.S.A. 
2.2.2 Preparation of R. 
The dried leaves of Ilex latifolia (E.) were blended to form a powder. The 
powder was then soaked in 100 volumes of water (w/v), boiled and allowed to 
simmer for two hours. The solution was filtered and centrifuged. The residue was 
sprayed dry and ready for use. 
2.2.3 Preparation of SEF 
0.5g n . was defatted with lL petroleum ether by soaking overnight. Then E. 
was extracted with methanol (2L) at 80°C for two hours. The extract was dried by 
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the rotatory evaporator. The residue was re-dissolved in water and extracted with 
water-saturated n-butanol. Then the n-butanol fraction was washed with water three 
times and dried with a rotatory evaporator. The residue was dissolved in water and 
freeze-dried to obtain the SEF. 
2.2.4 Animals 
Eight to twelve week-old male Balb/c mice were obtained from the Laboratory 
Animal Services Centre 0-ASEC) in the Chinese University of Hong Kong. The 
animals had free access to food and water before the experiments. 
2.2.5 Acute effect and sub-chronic effect of IL and SEF in normal mice 
The mice received an oral administration ofEL or SEF for 1 day. The mice were 
killed 24 hours later to collect blood for determination of AST and ALT activity. The 
weights of the liver, heart and kidney were also recorded. The liver was stored at -70 
°C before use in the MROD, EROD and GST assays. 
For investigating the sub-chronic effect ofEL and SEF, the mice received an oral 
administration of D^  or SEF daily for two weeks. The remaining procedure was the 
same as the experiment investigating the acute toxic effect of JL and SEF described 
above. 
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2,2�<J Tissue preparation 
Animals were killed to remove the liver. The liver was homogenized in 4 
volumes of O.lM sucrose containing 0.05M potassium chloride, 0.03M EDTA and 
0.04M potassium phosphate (pH 7.2) using a Potter-Elvehjem homogenizer. The 
homogenate was centrifuged at 12,000g for 20 min at 4°C. The supernatant obtained 
was centrifuged again at 105,000g for 60 min twice. The supernatant was collected 
for the determination of cytosolic GST activity (Section 2.2.7). The pellet obtained 
was resuspended in the homogenizing buffer by gentle homogenization with a loose-
fitting Teflon pestle. The preparations were stored at -70°C before use in the MROD, 
EROD and microsomal GST assays (Section 2.2.7). 
2.2.7Enzyme and protein assays 
(A) Methoxyresorufin 0-demethylase (MROD) and ethoxyresorufin 0-deethylase 
(EROD) acHtives 
The assay was performed according ofPohl and Fouts (1980). Twenty-five M-g of 
protein was incubated in 0.5ml of an assay medium containing O.lmM magnesium 
sulfate, 1.6mg bovine serum albumin, 1.5 i^M methoxyresorufin or ethoxyresorufin 
and 50mM potassium phosphate, pH7.5. The reaction was initiated by the addition of 
150 .^1 of a NADPH-regenerating system (0.2 unit of glucose-6-phosphate 
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dehydrogenase, 0.28mM NADP+and 2.5mM glucose-6-phosphate). After incubation 
at 37°C for 15 min, the reaction was terminated by precipitating the protein with 1ml 
methanol. After centrifugation, the supernatant fluid was taken for fluorescene 
measurement with an excitation wavelength of 530nm and an emission wavelength 
of 590nm. The amount of resorufin produced was determined with reference to the 
standard curve. 
(B) Glutathione-S-transferase (GST) 
GST activity was measured spectrophotometrically by following the absorbance 
increase at 345nm at 25 °C GST activity was determined in a reaction mixture 
consisting of 5mM glutathione and O.lM potassium phosphate (pH 8.5) containing 
lmM 1,2-dichloro-4-nitrobenzene as substrate. The GST activity was calculated 
based on an extinction coefficient of8,500M"^cm"^ for 1,2-dichloro^-dinitrobenzene. 
A complete assay mixture without enzyme was used as a control. 
(Q Alanine aminotransferase and aspartate aminotransferase 
The blood collected in section 2.2.5 was coagulated for 45 min in room 
temperature and then centrifuged at 2500 rpm for 5 min at 4°C to obtain serum. 
Serum AST and ALT enzyme activities were determined by using commercial 
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enzyme kits from Sigma. ALT or AST reagents were prepared according to the 
instructions of Sigma kit. Serum (O.lml) was added into AST or ALT reagent, mixed 
immediately and incubated at 30 °C for 90 seconds. Then the absorbance was read 
and recorded at 340nm as an initial absorbance. Water was used as reference. The 
incubation was continued for 60 seconds at 30°C. Absorbances at 30 seconds and 60 
seconds were recorded at 340nm. The absorbance reading at 60 seconds was final 
absorbance. The change of absorbance per min, obtained by subtracting final 
absorbance and initial absorbance can be determined to calculate AST and ALT 
activities. 
(D) Protein determination 
Protein was determined by the method ofLowry et al, (1951), using bovine 
serum albumin as the standard. 0.1 ml sample (buffer or standard) was mixed with 2 
ml reagent A which contains 1 volume of 1% CuSO/SI^O，1 volume of2% NaK-
tartrate and 100 volumes of 2% Na2CO3 in O.lM NaOH. The reaction mixture was 
allowed to stand for 10 min. 0.1ml Folin-Ciocalteu's phenol reagent was added and 
mixed immediately. The mixture was allowed to stand for 45 min before the 
absorbance at 750nm was measured. 
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22.8 Statistical analysis 
Statistical analysis was performed by using the Student's t-test. A p value of 
0.05 or below indicates statistically significant difference. 
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2,3 Results 
Z3,1 Acute effect ofIL andSEF as reflected in the body weight and weights of 
other tissues in normal mice 
The results of JL and SEF treatment on the body weight and weights of other 
tissues are shown in Tables 2.3.1 and 2.3.2 respectively. The body weights of the 
mice were maintained in all groups receiving JL. However the liver weights ofmice 
receiving JL (lgAcg) and H. (3g/kg) underwent a slight decrease. The differences 
were not statistically significant, however. Besides the weights of the heart and the 
kidney in all groups were also constant. The body, liver, heart and kidney weights of 
mice in the SEF group were also similar to those ofthe control. 
2.3.2 Sub-chronic effect ofIL and SEF as reflected in body weight and weights of 
other tissues in normal mice 
The results on EL and SEF treatment on the body weight and weight of other 
tissues are shown in Tables 2.3.3 and 2.3.4 respectively. Compared with the control, 
the body weights ofall EL treated group were slightly increased. The liver weights in 
all n . treated groups were higher than those of control. However all ofthem showed 
no statistically significant difference. There was no difference between all JL treated 
groups and control in the weight ofthe kidney and heart. The body, liver, kidney and 
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Table 2.3.1 Acute treatment with different concentrations of JL on body weight and 
liver，kidney and heart weights in mice 
Control JL (0.3gy^kg) R. (lg/kg) K> (3g/kg) 
Body Weight (g) 20.2±0.7 20.4±0.8 20.3±1.0 20.2±1.3 
H^rWeigh t (g ) 0.99+0.03 0.99±0.07 Q.95+Q.04 0.95±0.09 
Liver Weight 4.92+0.05 4.86+0.25 4.65+0.03 4.69±0.16~" 
(% ofB.W.) 
Kidney Weight 0.31+0.02 0.30+0.02 0.29±0.02 0.30土0.02""" 
(g) 
Kidney Weight 1.53±0.03 1.47±0.06 1.42±0.03 1.47±0.02 
(% ofB.W.) 
Heart Weight 0.10±0.00 0.09+0.01 0.10+0.01 0.10+0.01~~~ 
(g) 
Heart Weight 0.47±0.02 0.44±0.01 0.49士0.06 0.48+0.03 
(% ofB.W.) 
The mice received either water or EL at different concentration once. Their body 
weight, liver weight，kidney weight and heart weight were recorded at the end ofthe 
experiment which lasted for 1 day. All values are presented as means 土 S.D. of 5 
mice. No statistically significant change due to JL were detected. 
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Table 2.3.2 Acute effects of SEF on the body weight and liver，kidney and heart 
weights in mice 
Control SEF (lOOmgy^ kg) 
Body Weight (g) 20.7±0.7 20.9±0.8 
"""LiverWeight(g) 0.99±0.07 ^.98+0.03 
Liver Weight 4.79+0.45 4.70+0.12 
(% ofB.W.) 
Kidney Weight (g) 0.29+0.01 0.30土0.01 
Kidney Weight 1.41土0.07 T A l ^ 
(o/o ofB.W.) 
Heart Weight (g) 0.10土0.00 0.10士0.01 
Heart Weight 0.48+0.02 0.47土0.05 
(% ofB.W.) — 
The mice received either water or SEF once. Their body weight，liver weight，kidney 
weight and heart weight were recorded at the end ofthe experimental period which 
lasted for 1 day. All values are presented as means 土 S.D. of 5 mice. No statistically 
significant change due to SEF were detected. 
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Table 2.3.3 Sub-chronic effect ofdifferent concentrations ofK. on body weight 
and liver, kidney and heart weights in mice 
Control JL (0.3g/kg) EL(lg/kg) JL (3g/kg) 
Body Weight (g) 19.4±0.8 19.7+1.2 20.1+0.7 19.8i0.7 
LiverWeight(g)~~1.02±0.05 0.96+0.03 1 01±0.06 0.97+0.05~~ 
Liver Weight 5.29+0.24 4.87±0.24 5.02±0.29 4.90+0.28 
(o/o ofB.W.) 
Kidney Weight 0.30±0.01 0.30土0.01 0.29±0.01 0.30土0.01 
(g) 
Kidney Weight 1.55+0.06 1.51+0.10 1.46+0.01 1-30+0.05 
(o/o ofB.W.) 
Heart Weight 0.10±0.00 0.10+0.01 0.10+0.01 0.10i0,01 
(g) - - — — 
Heart Weight 0.50+0.04 0.52+0.05 0.48+0.03 0.50±0.04 
(o/o ofB.W.) 
The mice received either water or JL at different concentrations once a day for 14 
days. Their body weight, liver weight, kidney weight and heart weight were recorded 
at the end ofthe experimental period. All values are presented as means 土 S.D. of 5 
mice. No statistically significant change due to EL were detected. 
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Table 2.3.4 Sub-chronic effects of SEF on body weight and liver, kidney and heart 
weights in mice 
Control SEF (lOOn^kg) _ 
Body Weight (g) 20.5土1.3 20.6+1.2 
Liver Weight (g) 1.00土0.08 1.06±0.10 
LiverWeight (% ofB.W.) 4.91+0.50 5.16±0.63 
Kidney Weight (g) 0.29±0.02 0.28土0.02 
Kidney Weight 1.44+0.17 1.38士0.15 
(% ofB.W.) 
Heart Weight (g) 0.10士0.01 0.10士0.01 
Heart Weight (% ofB.W.) 0.51±0.05 0.47土0.02 
The mice received either water or SEF once a day for 14 days. Their body weight, 
liver weight，kidney weight and heart weight were recorded at the end of the 
experimental period. All values are presented as means 土 S.D. of 5 mice. No 
statistically significant change due to SEF were detected. 
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heart weights in SEF-treated were similar to those in control animals. 
2*丄3 Acute effects ofIL and SEF on the AST andALT activities in normal mice 
The results for acute effect o fE . and SEF on AST and ALT activities are shown 
in Tables 2.3.5 and 2.3.6 respectively. The normal ranges ofAST and ALT in Balb/c 
mice were 50-200 pimole/min/L and 30-150^unole/miny0:^  respectively. The AST 
activities in all H>-treated groups were within 15 % compared with control. ALT in 
all n.-treated groups was similar to that of control. The AST and ALT levels in SEF 
treated group were also similar to those of the control. All AST and ALT level in two 
sets ofexperiments were within the normal range. 
2'3.4 Suh-chronic effect of U. and SEF on AST andALT activities in normal mice 
The results for sub-chronic effect ofEL and SEF on AST and ALT activities are 
shown in Table 2.3.7 and 2.3.8. After administration ofIL for two weeks, AST level 
in IL (lg/kg) and JL (3gyTcg) groups were slightly increased. However the AST level 
in all n . treated groups were within 20 % compared with the control and the 
difference were not statistically difference. ALT level in all E. treated groups were 
similar to that of control. AST and ALT levels in SEF treated group were also similar 
to those ofcontrol. All data were within the normal range. 
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Table 2.3.5 Acute effect ofdifferent concentrations o fE . on serum AST and ALT 
activities in mice 
Semm enzyme activity (M,mole/minyT>) 
AST ALT 
C ^ 104.1±31.9 46.8土9.2 
JL (0.3g/kg) 95.7+22.7 44.9土11.7 
n . (lg/kg) 93.7+22.6 37.\±5.9 
n . (3g/kg) 93.9+22.0 36.7±2.6 
The mice received either water or E. (different concentrations) once. Enzyme 
activities were determined as described in Materials and Methods. All values are 
presented as means 土 S.D. of 5 mice. No statistically significant change due to JL 
were detected. 
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Table 2.3.6 Acute effect ofSEF on serum AST and ALT activities in mice 
Serum enzyme activity (Hjnole/min/L) 
AST ALT 
C ^ 89.2+10.1 43.3+6.8 
SEF (lOOmg/kg) 85.2+18.2 ^9.3+5.3 
The mice received either 5% ethanol or SEF once. Enzyme activities were 
determined as described in Materials and Methods. All values are presented as means 
士 S.D. of5 mice. No statistically significant change due to SEF were detected. 
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Table 2.3.7 Sub-chronic effect of different concentrations ofE> on serum AST and 
ALT activities in mice 
Serum enzyme activity (^imole/min/L) 
A ^ Auf 
Control 86.7±18.6 44.4+8.7 
n . (0.3g/kg) 88.1±23.1 43.5+5.0 
DL(lg/kg) 103.4±15.8 46.5+6.0 
EL(3g/kg) 94.4±24.5 42.5+9.8 
The mice received either water or JL (different concentrations) once a day for 14 
days. Enzyme activities were determined as described in Materials and Methods. All 
values are presented as means 土 S.D. of 5 mice. No statistically significant change 
due to EL were detected. 
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Table 2.3.8 Sub-chronic effect ofSEF on semm AST and ALT activities in mice 
Serum enzyme activity (^imole/miny'L) 
A ^ ALT 
Control 94.6+12.5 39.6+8.2 
SEF (lOOmgy^ kg) 87.9±13.1 44.9+10.2 
The mice received either 5% ethanol or SEF daily for 14 days. Enzyme activities 
were determined as described in Materials and Methods. All values are presented as 
means 土 S.D. of5 mice. No statistically significant change due to SEF were detected. 
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2J. 5 Acute effect of IL and SEF on various xenobiotic enzymes in normal mice 
The results ofEL and SEF are shown in Tables 2.3.9 and 2.3.10 respectively. 
MROD: Compared with the control, all JL treated groups had similar MROD 
activity. The result of SEF-treated group on MROD activity was similar 
to that ofD^. They had no induction effect on MROD activity. 
EROD: Compared with the control, all IL treated groups had no induction effect 
in EROD activity. The result of SEF group was similar to that of JL 
treated groups. 
GST: Compared with the control，both JL (lgy^kg) and JL (3gy^ kg) significantly 
induced cytosolic GST activity by 47% and 52% respectively. They also 
significantly induced microsomal GST activity by 31 % and 43 % 
respectively. JL (0.3gy^kg) also slightly but not significantly induced 
cytosolic and microsomal GST activity. SEF did not alter cytosolic and 
microsomal GST activities. 
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Table 2.3.9 Acute effect of different concentrations ofIL on the activities of various 
detoxifying enzymes in mice 
Enzyme activity 
MROD EROD GST ^ 
(cytosolic fraction) (microsomal fraction) 
pmole/min/mg pmole/min/mg ^imole/miny'mg i^mole/miny^mg 
~~Control 358+40 275±41 2.28土0.38 5.00±0.55 
n^0.3gA:g) 387±95 339+57 2.79±0.56 5.38±1.29 
EL(lg/kg) 317+61 3 0 1土 4 7 3.37±0.63* 6.56±0.86** 
EL(3g/kg) 403+56 276±32 3.47+0.81** 7.15+1.22** 
Mice received either water or JL at different concentrations for 1 day. Enzyme 
activities were determined as described in Materials and Methods. All values are 
presented as means ± S.D. of 5 mice. 
*p< 0.05, **p<0.01, significantly different from control by Student's t-test, 
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Table 2.3.10 Acute effect of SEF on the activities of various detoxifying enzymes in 
mice 
Enzyme activity 
MROD EROD G ^ ^ 
(cytosolic fraction) (microsomal fraction) 
pmole/min/mg pmole/min/mg ^imole/min/mg ^unole/minAng 
Control 379±67 398+58 2.22±0.29 4.48db0.66 
SEF (lOOmgA:g) 435±53 410+34 2.41±0.27 4.79±0.58 
Mice received either water or SEF for 1 day. Enzyme activities were determined as 
described in Materials and Methods. All values are presented as means 士 S.D. of 5 
mice. No statistically significant change due to SEF were detected. 
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2.3,6 Sub'Chronic effects of K and SEF on various xenobiotlc enzymes in normal 
mice 
The sub-chronic effects ofEL and SEF are shown in Tables 2.3.11 and 2.3.12. 
MROD: After treatment with JL at different concentrations for two weeks, only EL at 
the dose of (lg/kg) elevated MROD activity by 15 %. The increase was not 
statistically significant. Compared with the control, SEF had no induction 
effect on MROD. 
EROD: Compared with the control, different doses of JL had no augmenting effect 
on EROD. SEF also yielded similar results. 
GST: All dosages of BL significantly induced cytosolic GST activity. H. (lg/kg) 
and 化(3gy^kg) induced cytosolic GST activity by about 77% and 72% 
respectively. JL (0.3gy'kg) induced cytosolic GST activity by 43%. For the 
microsomal GST activity，JL (lg/kg) and EL (3g/kg) significantly induced 
GST activity by 46% and 54% respectively. JL (0.3gy'kg) induced GST 
activity by 23% although the change was not statistically significant. SEF 
had no induction effect on cytosolic and microsomal GST activity. 
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Table 2.3.11 Sub-chronic effects of different concentrations JL of on the activities 
ofvarious detoxifying enzymes in mice 
Enzyme activity 
MROD EROD G ^ G ^ 
(cytosolic fraction) (microsomal fraction) 
pmole/min/mg pmole/minAng punole/minAng M-mole/min/mg 
~~Control 363+58 310±44 2.17±0.64 4.86+0.75 
EL(0.3gy^g) 385+59 319±39 3.11±0.74* 6.04±1.43 
EL(lg/kg) 420±76 325±26 3.85±0.76** 7 . 1 2土 1 . 0 3 * * * 
DL(3gyOcg) 383±52 339±40 3 . 7 4 + 0 6 1 * * * 7.50±1.07*** 
Mice received either water or JL at different concentrations for 14 days. Enzyme 
activities were determined as described in Materials and Methods. All values are 
presented as means 土 S.D. of 5 mice. 
*p< 0.05, **p<0.01, ***p<0.005, significantly different from control by Student's 
t-test. 
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Table 2.3.12 Sub-chronic effect of SEF on the activities of various detoxifying 
enzymes in mice 
Enzyme activity 
MROD EROD G ^ G ^ 
(cytosolic fraction) (microsomal fraction) 
Pmole/min/mg pmole/min/mg n>mole/minAng |amole/mi"mg 
Control 279±22 292±32 2.14i0.26 4.75±0.50 
SEF(lOOmg/kg) 308±36 276±30 2.22±0.18 4.34±0.48 
Mice received either water or SEF for 14 days. Enzyme activities were determined as 
described in Materials and Methods. All values are presented as mean 土 S.D. of 5 
mice. No statistically significant change due to SEF were detected. 
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2,4, Discussion 
Weight loss is one indicator for toxicity. One example is that caused by 
administration of a high dose of simvastatins for twelve days, which can be used to 
treat hypercholesterolemia, caused liver necrosis with centrolobular degeneration, 
along with anorexia, weight loss and death (Diaz-Zagoya et aL, 1999). In the present 
study, oral administration ofEL and SEF for one day，there was no significant change 
in body weight and liver weight. The results ofEL and SEF after two weeks were the 
same as that of t t . and SEF after one day. Besides, administration of t t . and SEF also 
had no effect on the heart and kidney weights. It indicated that administration of JL 
and SEF had no lethal effect. 
In the present investigation, oral administration ofIL for one day and two weeks 
had no effect on serum levels of AST and ALT. According to Kong (unpublished 
data), oral administration of EL for 45 days and 90 days also had no effect on serum 
AST and ALT activities. The results indicated that acute, sub-chronic and chronic 
administration ofEL did not cause any liver cell damage. Besides JL did not exert any 
effect on the body weight and weight of other tissues. It indicated that chronic 
administration ofIL did not cause any observable damage in important tissues. 
Saponins have a reputation for being highly toxic. It is because saponins possess 
the ability to haemolyze red blood cells (Butler et aL, 1973). They tend to alter the 
permeability ofthe cell wall and therefore exert a general toxicity on many organized 
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tissues. However the toxicity of saponin administered orally is low except for the 
saponin from common com cockle {Agostemma githage). The oral lethal dose ofthe 
saponin from common com cockle foT dogs was 25-30mg/kg. The low toxicity of 
saponin is due to complete failure for it to cross the gut wall and enter the blood 
stream (Oakenfull et aL, 1990). Hence the hemolytic activity ofsaponin is reduced. It 
can also be reflected from the results regarding SEF (Sections 2.3.1 and 2.3.2). Oral 
administration of SEF did not cause any death after one day and after two weeks. 
SEF also had no effect on serum AST and ALT activities. It indicated that SEF did 
not cause any cell damage. 
Xenobiotic chemicals may be considered to be non-nutritive, generally 
lipophilic, compounds that interact with organism to display toxic and sometimes 
carcinogenic effects. The duration and intensity of action of many xenobiotics within 
the biological systems are determined by the rate of their biotransformation to 
pharmacologically active or inactive products. The liver is the major organ for 
detoxifying xenobiotic chemicals to protect the body from damage. The 
detoxification of xenobiotic chemicals involves two phases: cytochrome P450 (phase 
I enzyme) and phase H enzyme. Cytochrome P450 is the major enzyme system 
responsible for the metabolism of many drugs and foreign chemicals to polar 
metabolites, thereby facilitating their elimination from the body (Wackett et al., 1982; 
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Obermeier et al., 1995). The existence of multiple forms of cytochrome P-450 is well 
known，and the composition of these isoforms in tissues as well as relative 
concentrations is influenced by treatment with different chemicals. The second step 
involves phase H enzymes such as GST，which can convert the metabolites into an 
soluble form for elimination. GST plays a physiological role in initiating the 
detoxification of potential alkylating agents, including pharmacologically active 
compounds fHabig et al., 1974). These enzymes catalyze the reaction of compounds 
with -SH group of glutathione, thereby neutralizing their electrophilic sites and 
rendering the products more water-soluble. The glutathione conjugates can be further 
metabolized for excretion. 
According to Zhong Yao Da Ci Dian (1977), one effect o fE . is detoxicification. 
It may involve induction of certain liver enzymes. Therefore various xenobiotic 
enzymes were tested. After oral administration of EL for one day，none of the doses 
o f E . had any effect on EROD or MROD activity. However EL (lg/kg and 3g/kg) 
induced both cytosolic and microsomal GST activity. The results of R> 
administration for two weeks were similar to those of BL administration for one day. 
They indicated that JL induced GST activity. As mentioned before, GST is one of the 
detoxifying enzymes. Muction of GST can enhance the removal of the metabolites 
of xenobiotics. Therefore the detoxifying effect of JL may be related to induction of 
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phase II enzymes. 
SEF had no effect on the activities of MROD, EROD and GST. It may be 
related to the low solubility of SEF (Oakenfull et al., 1989). Little SEF can enter into 
the blood stream and as a result it is difficult for SEF to affect the liver enzymes. 
Comparing the results o f E . and SEF from two sets of experiment, administration for 
one day and administration for two weeks，it was found that only JL could induce the 
GST activity. Thus the effect of EL on enzyme induction may not be related to the 
saponin fraction. Some studies stated that polyphenols in green tea could induce GST 
activity (Bu-abbas et al., 1998). Green tea is rich in polyphenol. JL also contains 
about 8 % of polyphenols, the effect of JL in inducing GST may be related to the 
presence of polyphenols. 
In the present investigation, although SEF had no effect on the various 
xenobiotic enzymes, SEF may also contribute to a protective effect in other 
approaches. One example is the effect of a-hederin, which is a triterpenoid saponin 
found in herbs such as Lonicera fulvotomentosa. Cadmium (Cd) is an environmental 
pollutant which can cause liver damage. Liu et al. (1993) found that a-hederin 
induced metallothionein (MT) which is a metal binding protein for protection against 
the hepatotoxicity of Cd. It induced MT, which binds Cd in the cytosol thus reducing 
the amount of Cd in the critical cellular organelles and then decreasing the 
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hepatotoxicity by Cd. SEF can also be used to study the protection against the 
hepatotoxicants. 
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Chapter 3 Hypoglycemic effect ofIlex latifolia 
extract and its saponin-enriched fraction 
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Diabetes mellitus is a syndrome of disordered metabolism with inappropriate 
hyperglycemia due either to an absolute deficiency of insulin secretion or a reduction 
in the biological effectiveness of insulin. Diabetes mellitus can be classified into two 
major types according to the dependence on exogenous insulin. The two types of 
diabetes include (1) diabetes associated with insulin deficiency (Type I, insulin-
dependent, HDDM) and (2) diabetes associated with insulin resistance (Type H, 
noninsulin-dependent, NK)DM) (Karan et aL’ 1994). 
The approaches to the control and prevention of hyperglycemia are central to 
the management of diabetes mellitus (Gray et al., 2000). The development of new 
dietary adjuncts and novel antidiabetic agents, which reinstate a normal metabolic 
environment, thereby reducing the long-term complications associated with diabetes 
is required. 
3.1.2 Herbal medicines 
Throughout the world，many traditional plant treatments for diabetes exist and 
therein lies a hidden wealth of potentially useful natural products for diabetes control 
{Qid,yetal., 1997a). 
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Recent studies showed that aqueous extracts ofagrimony (Agrimony eupatoha), 
lucerne {Medicago sativa), coriander {Coriandrum sativum), eucalptus {Eucalyptus 
globulus) and edible mushroom {Agaricm campestis) enhanced insulin secretion and 
mimicked the effect of insulin on glucose metabolism in vitro (Gray et al., 1997b; 
1998a,b,c; 1999a,b). The dual pancreatic and extrapancreatic actions would prove to 
be an important advance on existing therapies used to treat and control diabetes, such 
as oral hypoglycemic drugs, which act either by enhancing insulin secretion, by 
improving the action of insulin or by interfering with glucose absorption and 
utilization. These combined findings illustrate the enormous potential of plants for 
use as possible dietary adjuncts and the discovery of natural products for diabetic 
therapy. 
3A,3 Objectives 
The aim of this investigation was to study the acute hypoglycemic effect of U^  
and SEF on normal mice when fed with glucose simultaneously and when fed before 
glucose administration. The acute hypoglycemic effects of JL and SEF in diabetic 
mice were studied. Moreover the hypoglycemic effects of repeated administrations of 
EL and SEF on diabetic mice were also studied. 
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3,2 Materials and Methods 
3.2.1 Materials 
Streptozotocin, citric acid，ethanol, glucose and sodium citrate were obtained 
from Sigma. H. powder and SEF powder were obtained from the Biochemistry 
Department of the Chinese University of Hong Kong. Tolbutamide was obtained 
from Ko Wah apothecary. 
3.2.2Animals 
Eight to twelve week-old male Balb/c mice were obtained from the Laboratory 
Animals Services Center in the Chinese University ofHong Kong. The animals had 
free access to food and water before the experiment. 
3,2,3 Induction of diabetes 
Diabetes was induced by an intraperitoneal streptozotocin injection after 
ovemight fasting. Streptozotocin was dissolved in 0.5ml of freshly prepared sodium 
citrate buffer (lOmM, pH4.5) and injected at a concentration of lOOmg/kg body 
weight. Eight days after injection of streptozotocin，the serum glucose level of all the 
mice were determined. Mice with a serum glucose level above 250 mg/dl were 
considered to be diabetic and were used in the following experiments. 
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3.2.4, Determination of serum glucose level 
Serum glucose level was determined by using an enzymatic kit from Sigma 
Chemical Co. The serum was diluted 20 fold with distilled water. Then 25 ^il sample 
was added into 0.5 ml water and mixed with the Combined Enzyme-Color Reagent 
Solution from Sigma. Water and glucose standard solution were used as blank and 
standard respectively. The reaction mixture was incubated at 37°C for 30 min and 
then the absorbance was read at 450nm against the blank. The glucose concentration 
can be determined from the standard curve. 
3.2.5. Effects on blood glucose level when IL orSEF was fed simultaneously with 
ghicose 
EL (0.3gyTcg, lg/kg and 3gy1cg) or SEF (33mg/kg and lOOmg/kg) with glucose 
1.5g/kg were fed at 0 min to male mice which had been fasted ovemight. Control 
mice were fed either water or 5 % ethanol with glucose. Mice fed with tolbutamide 
and glucose served as a positive control. The mice were killed at 0，30，60，90，120 
min to determine the serum glucose level. 
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3丄 6 Effects on serum glucose level when IL or SEF wasfed 30 min before the 
oral glucose load 
m (0.3g/kg, lg>^kg and 3g/kg) or SEF (33mgylcg and lOOmg/Ocg) was fed 30 min 
before the experiment to mice which had been fasted ovemight. The oral glucose 
load was given at time 0. Mice given either water or 5 % ethanol at 30 min before the 
experiment and then the glucose load was given at 0 min served as control. The 
group treated with tolbutamide was used as a positive control. Blood was collected 
at —30，0，30，60，90 and 120 min for determination of serum glucose level. 
3,2.7. Effects of /L or SEF on the serum glucose level in streptozotocin-induced 
diabetic mice 
The mice mentioned above in 3.2.3 were used. EL (0.3gy1cg, lg/kg and 3gy^g) or 
SEF (33mgAcg and lOOmg/kg) was fed at 0 min to mice which had been ovemight 
fasted. Blood was taken at different time points as in 3.2.6. 
3.Z8, Effects of repeated administrations of IL or SEF on serum glucose level in 
streptozotocin-induced diabetic mice 
Thirty-two mice (twenty-four diabetic mice and eight normal mice) were used 
in this study. They were housed, 8 mice per cage，in an animal room at constant 
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temperature (20-25°C) and with 12 hour light/dark cycles. The diabetic mice were 
fed water, JL (3gylcg) or SEF (lOOmgylcg) and tolbutamide (50mg/kg) daily for four 
weeks. The normal mice were treated with water as normal control. 5 % ethanol was 
used to substitute water for investigating the effect of SEF. Blood was collected after 
4 weeks following overnight fasting. The body weights of the mice and the number 
of deaths of the mice were also recorded. Mice were given free access to tap water 
and food throughout entire experimental period. 
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3.3Results 
3丄1 Oralglucose tolerance test 
The serum glucose levels after EL treatment are shown in Table 3.3.1. The peak 
of serum glucose level appeared 30 min after oral administration of glucose. The 
glucose level returned to basal level after 120 min. The serum glucose level after 
treatment o f E . (3g/kg) at 30 min was decreased by 10 % when compared with the 
normal control group and the difference was statistically significant (p<0.05). Serum 
glucose levels at 60 min and 90 min were also significantly reduced. Although JL 
( lg/kg) slightly decreased the serum glucose level at 30 min，the effect was not 
significant. EL at the dose of 0.3gyTcg was not capable of lowering serum glucose 
level，indicating that only the highest concentration of JL reduced the serum glucose 
level in normal mice. Tolbutamide, which reduces serum glucose level by inducing 
insulin secretion, served as a positive control. As shown in Figure 3.3.1, its 
hypoglycemic effect was significant at all time points except 0 min. 
The effects of SEF on oral glucose tolerance in normal mice are shown in 
Figure 3.3.2. Only saponin (lOOmg/kg) lowered serum glucose level significantly at 
all time points except time 0. The reduction in serum glucose level was about 10 % 
when compared with the normal control. Although SEF slightly reduced the serum 
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Figure 3.3.1 Effect of oral administration of different concentrations ofEL 
on oral glucose tolerance in normal mice. Water, JL or tolbutamide 
was administered simultaneously with 1.5 g/kg glucose at time 0 
after ovemight fasting. 
The serum glucose level was determined as described in Materials and 
Methods * p < 0.05，** p < 0.01，*** p < 0.005, significantly different 
from the corresponding control level. The data are presented as 
means 土 S.D. N 二 6 mice in each group. 
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Figure 3.3.2 Effect of oral administration of different concentrations of SEF 
on oral glucose tolerance in normal mice. 5 % ethanol, 
SEF or tolbutamide was administered simultaneously with 1.5 g/kg 
glucose at time 0 after ovemight fasting. 
The serum glucose level was determined as described in Materials 
and Methods * p < 0.05, * * * p < 0.005, significantly different from 
the corresponding control level. The data are presented as 
means 土 S.D. N = 6 mice in each group. 
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3.3.2 Effects on serum glucose level when IL or SEF wasfed 30 min prior to 
oral glucose load 
The effects ofdifferent doses o fE . on serum blood glucose level in normal mice 
are shown in Figure 3.3.3. Only the highest dose o f E . (3g/1cg) significantly lowered 
serum glucose level at 30 min and 60 min. It brought about 14 % reduction in 
glucose level when compared with the normal control. It seems that the 
hypoglycemic effect of JL fed before the oral glucose load was stronger than that of 
D- fed simultaneously with glucose. However, the other dosages of JL only weakly 
reduced serum glucose level. 
The effects of SEF on serum glucose level were also studied. The results are 
shown in Figure 3.3.4. The hypoglycemic effect of SEF was observed at the highest 
dose (lOOmg/kg) and the effect was significant at all time points except 0 min and 30 
min. It could bring a reduction of about 14 % in serum glucose level. Compared with 
the effect of SEF shown in Figure 3.3.2, it exerted a stronger hypoglycemic effect. 
SEF at the dose of33mg/kg also had a glucose lowering effect which was significant 
at 30 min. 
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Figure 3.3.3 Effect of oral administration of different concentrations ofDL 
on the oral glucose tolerance in normal mice. Distilled water or 
EL was administered orally at -30 min after ovemight fasting and an 
oral load glucose (1.5g/kg) was given at time 0. Tolbutamide was 
also administered at time 0. 
The serum glucose level was determined as described in Materials and 
Methods * p < 0.05, ** p < 0.01，*** p < 0.005, significantly different 
from the corresponding control level. The data are presented as 
means 土 S.D.. N = 6 mice in each group. 
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Figure 3.3.4 Effect of oral administration of different concentrations of SEF 
on oral glucose tolerance in normal mice. 5 % ethanol or 
SEF was administered orally at -30 min after overnight fasting and 
an oral load of glucose (1.5g/kg) was given at time 0. Tolbutamide 
was also administered at time 0. 
The serum glucose level was determined as described in Materials and Methods. 
* p < 0.05，*** p < 0.005，significantly different from the corresponding 
control. The data are presented as means 土 S.D.. N = 6 mice in each group. 
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义丄3 Effect of IL or SEF on serum glucose level in streptozotocin-induced 
diabetic mice 
The effect of JL on serum glucose level in diabetic mice is shown in Figure 
3.3.5. In diabetic mice, the serum glucose level was three times higher than the basal 
level in normal mice. None of the doses of JL showed any hypoglycemic effect in 
diabetic mice. Tolbutamide (50mgyTcg) reduced the serum glucose level. 
The hypoglycemic effect of SEF in diabetic mice is shown in Figure 3.3.6. The 
results were similar to those ofEL in Figure 3.3.5. SEF did not reduce the serum 
glucose level in diabetic mice. 
3,3,4Repeated administrations of U. or SEF on serum glucose level in diabetic 
mice 
The effect o f H . on serum glucose level is shown in Figure 3.3.7. JL at the dose 
of 3g/kg was orally administered to diabetic mice once daily for 4 weeks，and the 
fasting blood glucose level was determined after 4 weeks. Repeated administrations 
of n . produced a significant decrease in the fasting blood glucose level compared to 
the diabetic control at week 4，while the control group showed an increase in the 
glucose level from the pre-treatment level (week 0). JL brought about 20 % reduction 
in glucose level in diabetic mice. L i the tolbutamide-treated group, the serum glucose 
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level showed a significant decrease when compared with the diabetic control group, 
n^ also minimized the body weight change and the mortality when compared with 
the diabetic control. The results are shown in Table 3.3.1. 
The effect of m on serum glucose level in diabetic mice is shown in Figure 
3.3.8. Repeated administrations of SEF brought about a significant decrease of about 
170/0 in serum glucose level when compared with the diabetic control. SEF also 
minimized body weight decrease and mortality when compared with the diabetic 
control. The result is shown in Table 3.3.2. 
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Figure 3.3.5 Effect of oral administration of different concentrations ofJL 
on serum glucose level in streptozotocin-induced diabetic mice. 
Water, E. or tolbutamide was administered at time 0 after 
ovemight fasting. 
The semm glucose level was determined as described in Materials 
and Methods. * * * p < 0.005, significantly different from the 
diabetic control. The data are presented as means 土 S.D. 
N = 6 mice in each group. 
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Figure 3.3.6 Effect of oral administration of different concentrations of SEF 
on glucose level in streptozotocin-induced diabetic mice. 5 % ethanol, 
SEF or tolbutamide was administered at time 0 after ovemight fasting. 
The serum glucose level was determined as described in Materials and 
Methods. * * * p < 0.005，significantly different from the diabetic control. 
The data are presented as means 土 S.D.. N = 6 mice in each group. 
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Figure 3.3.7 Effect of repeated administrations ofEL on serum glucose level in 
streptozotocin-induced diabetic mice 
NC: Normal control, DC: Diabetic control, JL : Ilex latifolia extract (3g/kg) 
TO: Tolbutaimde (50mgyTcg) 
Mice received BL，water or tolbutamide daily for 4 weeks. Glucose concentration was 
determined as described in Materials and Methods. A l l values are presented as means 
土 S.D. of 5-8 mice. The number of mice of each group is shown at the bottom of 
each bar. 
* * p < 0.01，*** p < 0.005，significantly different from the diabetic control by 
Student's t-test. 
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Table 3.3.1 Effects of repeated administrations ofIL on body weight change and 
mortality in streptozotocin-induced diabetic mice 
Initial body Final body % body Number of Mortality (%) 
weight (g) weight (g) weight gain deaths 
NC 21.8±O.9 24.5+1.1 12.4 0 0 
DC 21.9±1.0 15.2+1.2 -30.1 8 36.3 
IL 21.7±O.8 17.4±O.9 -19.6 4 18.2 
TO 21.6±O.8 19.1±1.5 -11.4 0 0 
NC: Normal control, DC: Diabetic control, IL: flex latifolia extract(3g/kg), 
TO: Tolbutamide (50mg/kg) 
Mice received water, IL or tolbutamide for 4 weeks. Body weight was recorded 
before and after the experimental period for all three sets of experiments. Mortality 
was calculated as the number of deaths divided by the total number of treated 
animals (22) in all three sets of experiments. 
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Figure 3.3.8 Effect of repeated administrations of SEF on serum glucose level in 
streptozotocin-induced diabetic mice 
NC: Normal control, DC: Diabetic control， 
SEF: Saponin-enriched fraction (lOOmg/kg), TO: Tolbutamide (50mgy^:g) 
Mice received SEF, 5% ethanol, or tolbutamide daily for 4 weeks. Glucose 
concentration was determined as described in Materials and Methods. Al l values are 
presented as means 土 S.D. of 6-8 mice. The number of mice in each group is shown 
at the bottom of each bar. 
*p < 0.05, * * * p < 0.005, significantly different from the diabetic control by 
Student's t-test. 
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Table 3.3.2 Effects ofrepeated administrations ofSEF on body weight change and 
mortality in streptozotocin-induced diabetic mice 
Initial body Final body % body Number of Mortality (%) 
weight (g) weight (g) weight gain deaths 
^ 21.5±0.7 24.5+1.2 I H 0 0 
DC 21.9+0.9 14.8±0.9 -30.1 6 27.3 
SEF 21.7±0.8 17.2±0.9 -19.6 1 4.5 
TO 21.6土1.3 18.2土1.3 -11.4 1 4.5 
NC: Normal control, DC: Diabetic control, 
SEF: Saponin-enriched fraction (lOOmgy^:g), TO: Tolbutamide (50mgA:g) 
Mice received water, SEF or tolbutamide for 4 weeks. Body weight was recorded 
before and after the experimental period for all three sets of experiments. Mortality 
was calculated as the number of deaths divided by the total number of treated 
animals (22) in all three sets of experiments. 
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3.4 Discussion 
The results of the present study demonstrated that both IL and SEF exerted a 
hypoglycemic effect in normal mice. Hypoglycemia could be observed only at the 
highest dose of IL and SEF. The glucose lowering effects of IL (3 g/kg) and SEF 
(100mg/kg) were similar as shown in Figures 3.3.1. and 3.3.2. However IL had a 
higher saponin content (about 600mg saponin in 3g IL) than SEF. It indicated that the 
glucose lowering effect of saponin was higher than that of IL. However neither IL 
nor SEF exhibited a hypoglycemic effect in streptozotocin-induced diabetic mice. 
Theoretically, the blood or serum glucose level after an oral glucose load depends on 
factors like intestinal motility, glucose absorption, insulin secretion, metabolic 
factors or glucose utilization (penchom et aI., 1995). 
The mechanism of acute hypoglycemic action of IL and SEF may not be due to 
changes in insulin secretion. The reason is that when comparing the effects of IL or 
SEF in normal mice and diabetic mice, it was found that they produced 
hypoglycemic effects only in normal mice. If they could stimulate insulin secretion, 
they would also have lowered the serum glucose level in both normal and diabetic 
mice. Although the mechanism of this hypoglycemic action is still unknown, the 
glucose lowering effect of other saponins may give us a clue on the mechanism of IL 
or SEF. Tea extracts inhibits intestinal absorption of glucose and sodium in rats 
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(Sawsan et al., 1994). Besides saponins can also affect gut permeability and active 
nutrient transport (Johnson et aL, 1986). One characteristic action of saponin is to 
induce hemolysis. It is because most saponins are highly surface-active, and many 
form addition complexes with sterols，including those associated with the plasma 
membranes o f fungal, plant and animal cells. This leads to membrane destabilization 
and cell lysis (Bondi et aL, 1973). From these characteristics of saponins, one 
possible mechanism ofDl> or SEF on lowering serum glucose level may be due to its 
inhibition of intestinal glucose absorption. 
The driving force for active glucose transport in the gut is provided by the 
presence of an electrochemical gradient for sodium across the brush-border 
membrane. It is maintained by active sodium extrusion at the basolateral membrane. 
The activity of this electrogenic pump gives rise to the substrate ~dependent 
transmural potential difference. The effect of saponin is to bind cell membrane ofgut 
and then reduce the permeability barrier to sodium at the brush border (such as 
inhibition of Na+-K+-ATPase, the enzyme for maintaining sodium gradient). The 
electrochemical gradient can be discharged and then the driving force for glucose 
transport can be removed. Moreover saponins may interact with the cell membrane 
and cause structural lesions. It would increase the turnover rate of intestinal mucosal 
cells, thus increasing the nutrient loss. Therefore JL or SEF may lower the serum 
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glucose level through this mechanism. However the effects of saponin on the 
electrochemical gradient on the cell membrane in gut had no effect on the serum 
glucose level. Therefore they had no effect on serum glucose level in diabetic mice. 
The streptozotocin-induced diabetic mice is a model of insulin-dependent 
diabetes mellitus (H)DM). Streptozotocin selectively destroys the pancreatic cells 
that secrete insulin, which causes less active pancreatic cells and produces diabetes 
mellitus (Like et aL, 1990). Tolbutamide is an anti-diabetic drug. It can stimulate the 
remaining pancreatic cells in diabetic mice to secrete insulin to lower the blood 
glucose level. Therefore it was used as a positive control. 
Moreover, the effects of repeated administrations of EL and SEF on the serum 
glucose level in diabetic mice were also studied. Both JL and SEF could reduce 
serum glucose level. However, the effects of saponin on the electrochemical gradient 
cannot be used to explain this phenomenon. The hypoglycemic effect of repeated 
administrations of JL or SEF may be due to other mechanisms. The research of 
Glombitza et al. (1993) on the hypoglycemic effects on Zizyphuss, a plant commonly 
used in Egyptian foUc medicine for the treatment of different diseases, may give 
some hints which may be used to explain the effect of JL or SEF. The results 
indicated that the saponin of Zizyphus not only decrease the serum glucose level, but 
also reduces hepatic glucose-6-phosphate phosphatase activity. Some saponins from 
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fengugreeh seeds have been reported to decrease glucagon level (Valette et al.’ 1984). 
One possible mechanism is that the glucagon lowering effect may enhance glucose 
utilization as indicated by increased hepatic glycogen，plasma pyruvate production 
and the decreased plasma glucose, hepatic phosphorylase, and glucose-6-phosphatase 
activities. Glycogen degradation can be rapidly stimulated by the direct hepatic 
action of different hormones. After that, glucagon exerts its glycogenolytic action 
through activation of adenyl cyclase leading to an increase in the level o f cAMP 
(Extron et al, 1972), a modulator of insulin secretion (Ferrel et al., 1979) and induce 
insulin secretion. Moreover decreasing glucose-6-phosphatase would reduce the level 
of glucose-6-phosphate, which can be used to activate glycogen synthetase. Then 
glycogen synthetase can be induced to decrease the serum glucose level. Besides, \L 
contains，in addition to saponin, many different components such as polyphenol or 
urosolic acid as mentioned in Chapter 1. Polyphenol can also inhibit cAMP 
phosphodiesterase (Ferral et aL, 1979). Therefore an elevated cAMP level can induce 
insulin secretion to lower the serum glucose level. It indicated that the hypoglycemic 
effect of repeated administrations of E> and SEF may involve more than one 
mechanism. Both JL and SEF contain many different components. It is difficult to 
conclude that the hypoglycemic effect of R. and SEF is due to a particular 
component. Therefore DL and SEF should be further purified to find out the 
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component( s) with hypoglycemic effect. On the other hand, the effect of IL and SEF 
on metabolic enzymes such as glucose-6-phosphatase can be tested to find out its 
mechanism. 
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Chapter 4 Hypolipidemic effect ofIlex latifolia 
extract and its saponin-enriched fraction 
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4.1 1 High serum cholesterol and triglyceride as a risk factor of CHD 
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4.2.1 Materials 
4.2 .2 Effect of repeated administrations o f t t . and SEF in normal mice fed with 
a high-cholesterol emulsion 
4.2.3 Effect of repeated administrations o fE . and SEF on serum cholesterol 
level and triglyceride level in hyperlipidemic mice 
4.2.4 Effect of repeated administrations ofDL and SEF on serum cholesterol and 
triglyceride level in diabetic mice 
4.2.5 Determination of serum triglyceride and cholesterol levels 
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4.3 Results 
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level in normal mice fed with a high-cholesterol emulsion 
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level in normal mice fed with a high-cholesterol emulsion 
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4.1.1. High serum cholesterol level and triglycerides as a risk factor of Coronary 
Heart Disease (CHD) 
A major medical disorder of the twentieth century is CHO. CHO accounts for 
over 260,000 deaths in the UK a year: more than four out of ten of all deaths (British 
Heart Foundation Health Promotion Research Group, 1999). There are many risk 
factors for CHO, such as smoking, diet and obesity. The concept of risk factors 
constitutes a major advance for developing strategies for preventing CHO. One of 
them is the serum cholesterol level. During the past 40 years, researchers have 
discovered a strong relationship between high concentration of serum cholesterol and 
CHO (Lipid Research Clinics Program, 1984). It may be due to the large amount of 
serum cholesterol that accumulates in the subintimal layer of the arteries to form 
plaques. The plaques are usually associated with degenerative changes in the arterial 
wall. They often protrude through the intima into the flowing blood and the 
roughness of their surfaces causes blood clots to develop, with resultant thrombus 
formation to cause death. 
Unlike serum cholesterol level, the relationship between CHO and serum 
triglyceride level is controversial. Hokanson et al. (1996) demonstrated that 
triglyceride is a risk factor for cardiovascular disease for both men and women in the 
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general population, independent of HDL cholesterol. Avins et al. (2000) observed 
that measurement of serum triglyceride level does not provide clinically meaningful 
information of CHO risk. National Institutes of Health Consensus Development 
Conference Statement (1992) indicated that the relationship between CHO and 
triglycerides cannot be concluded. Triglyceride-rich ·lipoproteins can be atherogenic. 
Furthermore, elevated triglycerides produce fibrinolytic activity, which may 
contribute over time to the atherosclerotic process. 
4.1.2 Diabetes induces hypercholesterolemia and hypertriglyceridemia 
Clinical and epidemiological reports have confirmed that cardiovascular disease 
IS the major cause of death in diabetic mellitus (Brain et al. , 1997). 
Hypercholesterolemia is a feature frequently observed in humans with diabetes 
mellitus and certainly contributes to the high prevalence of atherosclerosis and 
coronary heart disease associated with metabolic disorder (Pierre et a/., 1992). 
Cholesterol absorption is increased and the defect in the removal of lipoproteins 
through LDL receptors in diabetic mice may be the possible mechanism for the high 
cholesterol level (Shimida et aI., 1995). Besides, hypertriglyceridemia also occurs. It 
is because insulin can act on adipose tissue to promote triglyceride storage and 
inhibit intracellular lipolysis and increase hepatic triglycerides. A lack of insulin can 
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cause production of hepatic triglycerides and defective hydrolysis of serum 
triglycerides. Therefore it is important to control the blood levels of triglycerides and 
cholesterol in diabetic patients. 
4. L 3 Hypolipidemic effect of tea 
Tea is one of the most popular beverages in the Chinese society. Recently, tea 
has received much attention as a protective agent against CHD (Imai et aL, 1995). 
Increased consumption of green tea has been shown to be associated with decreased 
serum level ofcholesterol and triglyceride (Imai et al., 1995). Drinking green tea can 
affect the plasma lipoprotein level. Imai et al. (1995) showed that drinking green tea 
can increase the proportion of HDL-cholesterol level and decrease the proportion of 
LDL-cholesterol and VLDL-cholesterol. The effect of green tea on 
hypocholesterolemia may be due to the flavonoid content in green tea (Yang et al, 
1997). 
4, L 4 Hypolipidemic effect of Ilex latifolia and Saponin 
As mentioned in Chapter 1，one of the effects ofKudingcha is 
hypocholesterolemia. However supporting scientific evidence is lacking. L i et al. 
(1996) showed that Kudingcha could decrease serum triglycerides and cholesterol 
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level in hypercholesterolemic mice. Therefore JL may also demonstrate a 
hypocholesterolemic effect. 
Natural and synthetic saponins inhibit cholesterol absorption and reduce plasma 
cholesterol in experimental animals and are therefore of potential pharmacological 
utility in the treatment of hypocholesterolemia. Saponins are widely distributed in 
nature, forming a heterogeneous group of triterpenoid saponins and steroid 
glycosides of diverse biological activities that are themselves poorly absorbed from 
the intestinal tract, and interact with sterols in the intestinal lumen to prevent sterol 
absorption and hence lower the cholesterol level (Harwood et al, 1993). Many 
triterpenoid glycosides (saponins) were discovered in different types of Kudingcha 
CNakanishi et aI., 1981; Ouang et aL’ 1998). Moreover two kudingosides can be 
found in Kudingcha {Ligustrum pedunculare Rhed) as an inhibitor of acyl-CoA: 
cholesterol acyltransferase (ACAT) which catalyzes intracellular esterification of 
cholesterol. Therefore the saponins in Kudingcha may also reduce serum cholesterol 
level through cholesterol esterification. 
4A,5 Objectives 
Although the effect ofEL on serum cholesterol level has been studied, the effect 
o f n . and SEF is still unknown. Therefore the effect ofD^ at different concentrations 
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(0.3gy0cg, lg/kg and 3g/kg) on the serum triglyceride level and serum cholesterol 
level in mice with hypercholesterolemia and hypertriglyceridemia were studied. 
Besides the effect of SEF was determined. The effect of 正 and SEF on serum 
cholesterol and triglyceride levels in diabetic mice was also examined. 
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4,2 Material and Methods 
4.2,1 Materials 
Nicotinic acid, sodium hydroxide, hydrochloric acid，cholesterol, sodium 
cholate and sucrose were obtained from Sigma Chemical Co. Olive oil and lard were 
obtained from a local supermarket. 
4.2.2, Effect of repeated administrations of IL and SEF in normal mice fed with a 
high-cholesterol emulsion 
Eight to twelve week-old male Balb/c mice were housed in an animal room on a 
12h light/dark cycle (light: 0600-1800) period in LASEC ofthe Chinese University 
of Hong Kong. They were randomly divided into four groups and were fed a high-
cholesterol emulsion with different drugs. The method described by Morishita et aL 
(1986) was modified and used to prepare the high-cholesterol emulsion. Three 
groups of mice (the experimental group) were fed a high-cholesterol emulsion 
(cholesterol 4.5g, cholic acid sodium salt 1.5g, sucrose 50g, lard 60g, distilled water 
39ml) daily at noon for 4 weeks. E> at different concentrations were orally 
administered daily for 4 weeks two hours after administration of a high-cholesterol 
emulsion. For the positive control, nicotinic acid was orally administered instead of 
JL. Water instead of JL was administered into negative control The normal control 
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group was treated with a control emulsion (sucrose 56g, olive oil 60g and water 39 
ml) and water. The experiment to investigate the effect of SEF was the same as that 
of DL. Blood samples were collected before the commencement of the experiment, 
and again on day 15，day 22 and day 29 after ovemight fasting. The mice had free 
access to food and water during the experimental period. 
4,2,3 Effects of repeated administrations of ZL or SEF on serum cholesterol level 
and triglyceride level in hyperlipidemic mice 
Mice were fed with a high-cholesterol emulsion for two weeks to elevate the 
serum cholesterol and triglyceride levels. EL or SEF was administered daily for 4 
weeks after hyperlipidemia had been achieved. Blood was taken before and after 
administration of the samples to determine the serum cholesterol and triglycerides 
levels. 
4.2.4Effects ofrepeated administrations of IL or SEF on serum cholesterol and 
triglyceride levels in diabetic mice 
The streptozotocin-induced diabetic mice mentioned in Section 3.2.7 were used. 
Blood was taken before and after the experiment to determine serum cholesterol and 
triglyceride levels. 
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4,2,5 Determination of serum triglyceride and cholesterol level 
Serum levels of triglyceride and cholesterol were determined by using the 
enzymatic kits from Sigma Chemical Co. For the determination of cholesterol, 
0.01ml serum was mixed with cholesterol reagent from Sigma and the mixture was 
incubated in water bath at 37°C for 10 min. Water was used as the blank. Absorbance 
was read at 500nm and the serum cholesterol level can be calculated. For the 
determination of triglyceride, 10 pil serum was mixed with triglyceride reagent from 
Sigma and the mixture was incubated for 5 min at 37°C. Water was used as the blank. 
Absorbance at 540nm was read to determine the serum triglyceride level. 
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4,3, Results 
4.3.1 Effect of repeated administrations of 2L andSEF in serum cholesterol level 
normal mice fed with high-cholesterol emulsion 
The effect of JL at different concentrations (0.3gyTcg, lgylcg and 3gy^g) on the 
cholesterol level is shown in Figure 4.3.1. The effect of SEF is shown in Figure 4.3.2. 
The serum total cholesterol level in the mice was monitored throughout the 
experiment. 
Before cholesterol feeding, no difference was observed between the serum 
cholesterol levels of both normal and high cholesterol groups. After 14 days of 
feeding a high-cholesterol emulsion, an increase in serum cholesterol level was 
observed in the treated groups. No change occurred in control group. It was found 
that n . at the highest dose (3g/kg) significantly reduced the cholesterol level by 12% 
at days 15，22 and 29 ^*igure 4.3.1). However the two lower doses ofEL (0.3g/kg and 
lgy^g) had no effect on serum cholesterol level at all time points. SEF showed a 
tendency to reduce serum cholesterol level at day 15，and also significantly lowered 
the cholesterol level by 9 % at days 22 and 29. Nicotinic acid, which was used as a 
positive control, lowered the serum cholesterol level in two sets of experiments 
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Figure 4.3.1 Effects of different concentrations of TL on serum total cholesterol 
level in mice fed a high-cholesterol emulsion. Mice received different 
concentrations ofE^, water or nicotinic acid daily for 4 weeks. Serum 
total cholesterol concentrations were determined as described in Materials 
and Methods. Data are presented as means 土 S.D.(n = ^ 
* p< 0.05，*** p < 0.005，significantly different from the high-cholesterol 
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.F igu re 4.3.2 Effects of SEF on serum total cholesterol level in mice fed a 
high-cholesterol emulsion. Mice received SEF, nicotinic acid 
or 5% ethanol daily for 4 weeks. Serum total cholesterol were 
determined as described in Materials and Methods. Data are 
presented as means 土 S D. (n = 5). 
* p < 0.05，** p < 0.01，*** p < 0.005, significantly different 
from the high-cholesterol control by Student's t-test. 
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4.3,2 Effect of repeated administrations of ZL and SEF in serum triglyceride level 
of normal mice fed with a high-cholesterol emulsion 
The dose response curve of JL at different concentrations on serum triglyceride 
level is shown in Figure 4.3.3. The effect of SEF is shown in Figure 4.3.4. 
Before feeding the high-cholesterol diet, there was no difference between all 
groups. The serum triglyceride level was elevated after two weeks of feeding and 
maintained at a high level thereafter when compared with the normal control. DL 
(3g/kg) brought a significant about 13% reduction of the serum triglyceride level. 
The other two doses (0.3gylcg and lg/kg) did not affect serum triglyceride level. SEF 
significantly reduced the level of serum triglyceride at all time points after 
establishment of hypertriglyceridemia. Nicotinic acid, a positive control, also showed 
a reducing effect on the serum triglyceride level. 
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Figure 4.3.3 Effects of different concentrations of K. on serum triglycerides 
level in mice fed with a high-cholesterol emulsion. Mice received 
different concentrations ofEL，water or nicotinic acid daily for 4 
weeks. Triglyceride concentrations were determined as described in 
Materials and Methods. Data are presented as means 土 S D. (n = 5). 
* p< 0.05，*** p < 0.005, significantly different from the high 
cholesterol control by Student's t-test. 
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Figure 4.3.4 Effects of SEF on serum triglycerides level in mice fed a high-
cholesterol emulsion. Mice received SEF, nicotinic acid or 5% 
ethanol daily for 4 weeks. Triglyceride concentrations were 
determined as described in Materials and Methods. Data are 
presented as means 土 S D. (n 二 5). 
* p <0.05, ** p < 0.01，*** p < 0.005，significantly different from the 
high triglycerides control by Student's t-test. 
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4.3,3 Effect of repeated administrations of K and SEF in the hyperlipidemic mice 
Mice were first fed with a high-cholesterol emulsion to elevate the serum levels 
of cholesterol and triglyceride. Different samples (EL or SEF) were fed daily for one 
month after establishment of hyperlipidemia. The results of JL treatment on serum 
cholesterol level and triglyceride level are shown in Figures 4.3.5 and 4.3.6 
respectively. The effects of SEF are shown in Figures 4.3.7 and 4.3.8. From the result 
of Figures 4.3.5 and 4.3.7, JL at the dose of 3g/kg, lowered serum cholesterol and 
triglyceride level. Compared with the high-cholesterol control and high-triglyceride 
control, n . significantly reduced the level of cholesterol by 11 % and serum 
triglyceride level by 7.5%. SEF also significantly reduced serum cholesterol level (15 
%) and triglyceride level (15%). When the effects o fE . and SEF are compared, both 
of them were found to have similar effects on reducing serum cholesterol and 
triglyceride levels. 
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Figure 4.3.5 Effects of repeated administrations ofEL on serum cholesterol level in 
hyperlipidemic mice. 
Mice received JL, nicotinic acid ^S[A) or water for 4 weeks. Serum total cholesterol 
concentration was determined as described in Materials and Methods. Data are 
presented as means 土 S.D. (n=5). 
*p < 0.05，** p < 0.01，significantly different from the high cholesterol control by 
Student's t-test 
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95 
1 8 0 . 0 0 「 — 一 — — ： 
.160.00 - DNC 
二 140.00 - . ‘ ， T* ** mm 
5 • »i ‘ . 
^ j j 々"* " * ^ ^ ^ V ^ i j V j • ^ |^  ^ "^^ ^^： '：二 ‘ rr)^'c* r.",^^?^ 
县 120.00 - ‘ A^^ T^  ^^ ,,《^^ jgg gHE!g rpi4^ t^ fr [4-^-^ 4^¾! 
I g g | g : ^ M ^ M 目以3由） 
i i _ - ^ i ^ ^ ^ ^ H ^ ^ ® 
,g ' r t % ^ "3' L " ^ ^ ^ m p | ^ ^ p ^ NA (lOOmg/kg) 
皇 80.00 - k $ ^ S ' - ' ^ ^ H ' ^ ^ ^ S L _ _ — 
2? ^^ ?^<^ '^ ¾^¾^  :----:rSS3HS^  1^ ¾¾ '^ S :¾¾¾ i 
'B T ‘ - ’ } : ^ ^ ^ ¾ ^ ^ ¾ ¾ ¾ ¾ ! 
I 60.00 - ~ ~：： ~ ~ l ^ ^ M t ^ ^ f S ^ i f i i I 
s ^ 5,r^^^^^ •-三§^至^£:上:•襄营^载^攀,守1 I 
o^  ^A^r^^^^ -若^^ ^；至；‘：S^ |^ p^| 1 
40-00 - l ^ ^ ^ ^ ; ^ ^ J ^ ^ _ I 
‘ • ‘ * . ' " 二二：二：：‘二二二：口二 : * T;r、t^ ?5>^5;^ t^34 t^i?r、CN5»-ht i 
"^^ ^^  ^ ^^ ^^ ^^  “ “ E"-!^ 3^FSEE^-  |^ ^^ ^^ J^|^ i^^ Sii^  1 
20.00 - ：译^^绕::•:-芸^^蜀 ^ ^ ^ ^ ^ ¾ ！ 
I ?F*;ilf^££i":;:^?d^j£L' ^ ^^ ;^i!i^ ^^ t^^ .^t>^ ^^ i j 
Q QQ ^ ‘ T ；二？?^ ;,:"^ :^翁掛.^ ^辑^^ *^  j 
Figure 4.3.6 Effects of repeated administrations ofDL on serum triglyceride level in 
hyperlipidemic mice. 
Mice received JL, nicotinic acid fNA) or water for 4 weeks. Triglyceride 
concentration was determined as described in Materials and Methods. Data are 
presented as means 土 S.D. (n=5). 
*p < 0.05, ** p < 0.01，significantly different from the high-triglyceride control by 
Student's t-test 
NC = Normal control，HT = High-triglyceride control 
96 
250.00「. . -“—-.. ...”•.—.- - - -1 
• NC 
^ 200.00 - •… 
§ _HC 
I 譯 國 * 
S _ ^ ^ : , 3 ^ ^ j ** SSEF(lOOmg/kg) 
^ 150.00 h ^ ^ ^ ^ ^鎮 > ^ ^ ^ y ^ 
^ ^ • i B ^ H 
• _ ：^^  
• * i M ® ^ 1 
|
議_ i 
_ _ I 
u u ^ j — - — • ~ = ^ ^ ^ ' ^ ^ ' ~ — " ? ^ | S ^ | i ^ : J i s ！ 
Figure 4.3.7 Effects of repeated administrations of SEF on serum total cholesterol 
level in hyperlipidemic mice. 
Mice received SEF, nicotinic acid fNA) or water for 4 weeks. Serum total cholesterol 
was determined as described in Materials and Methods. Data are presented as means 
土 S.D. (n=5). 
*p < 0.05，** p < 0.01，significantly different from the high cholesterol control by 
Student's t-test 
NC = Normal control, HC = High-cholesterol control 
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Figure 4.3.8 Effects of repeated administrations of SEF on serum triglyceides 
level in hyperlipidemic mice. 
Mice received SEF, nicotinic acid QS[A) or water for 4 weeks. Triglyceride 
concentration was determined as described in Materials and Methods. Data are 
presented as means 士 S.D. (n=5). 
*p < 0.05, ** p < 0.01，significantly different from the high-triglyceride control by 
Student's t-test 
NC = Normal control, HT = High-triglyceride control 
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4.3.4 Effect of repeated administrations of IL and SEF on serum cholesterol and 
triglyceride level in diabetic mice 
Insulin deficiency can cause disorders of triglyceride and cholesterol 
metabolism. Elevated serum cholesterol and triglyceride are found in diabetic 
animals. IL significantly reduced serum cholesterol level by 13% (Figure 4.3.9) and 
triglyceride level by 18% (Figure 4.3.10). SEF also significantly reduced serum 
levels of cholesterol by 13% and triglyceride by 16%. The effects of SEF on serum 
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Figure 4.3.9 Effect ofrepeated administrations o f E . on total serum cholesterol level 
in diabetic mice 
NC: Normal control, HC: High cholesterol control，JL : Ilex latifolia extract (3g/kg) 
TO: Tolbutamde (50mgy^kg) 
The number of mice in each group was indicated at the bottom of each bar. Mice 
received DL, water or tolbutamide daily for 4 weeks. Serum cholesterol 
concentrations were determined as described in Material and Methods. Al l values are 
presented as means 土 S.D. 
*p < 0.05，** p < 0.01，significantly different from the high cholesterol control by 
Student's t-test. 
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Figure 4.3.10 Effect ofrepeated administrations o f E . on serum triglycerides level in 
diabetic mice 
NC: Normal control, HT: High triglyceride control，JL : Ilex latifolia extract (3gy'kg) 
TO: Tolbutamide (50mgyTcg) 
The number of mice in each group was indicated at the bottom of each bar. Mice 
received JL, water or tolbutamide daily for 4 weeks. Serum triglyceride 
concentrations were determined as described in Materials and Methods. A l l values 
are represented as mean 土 S.D. 
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Figure 4.3.11 Effect ofrepeated administrations ofSEF on serum total cholesterol 
level in diabetic mice 
NC: Normal control, HC: High-cholesterol control， 
SEF: Saponin-enriched fraction (lOOmgA:g), TO: Tolbutamide (50mg/'kg) 
The number of mice in each group was indicated at the bottom of each bar. Mice 
received SEF，5% ethanol or tolbutamide daily for 4 weeks. Semm cholesterol 
concentrations were determined as described in Materials and Methods. Al l values 
are presented as means 土 S.D. 
*p < 0.05, ** p < 0.01，significantly different from the high-cholesterol control by 
Student's t-test. 102 
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Figure 4.3.12 Effect of repeated administrations of SEF on serum triglyceride level 
in diabetic mice 
NC: Normal control, HT: High-triglycerides control, 
SEF : Saponin-enriched fraction (lOOmgyTcg)，TO: Tolbutamide (50mgy'kg) 
The number of mice in each group was indicated at the bottom of each bar. Mice 
received SEF, 5 % ethanol or tolbutamide daily for 4 weeks. Serum triglyceride 
concentration was determined as described in Materials and Methods. Al l values are 
presented as means 土 S.D. 




Both JL (3gyOcg) and SEF (lOOmgyOcg) lowered the serum cholesterol and 
triglyceride levels in all three sets of experiments: effect on mice fed with a high-
cholesterol emulsion, effect in hyperlipidemic mice and in streptozotocin-induced 
diabetic mice. The results regarding SEF and JL were similar. However IL had a 
higher saponin content than as mentioned in Chapter 1. It indicated that SEF may 
exert more potent hypolipidemic action than E>. It is because the presence of other 
components such as flavonoids in U. may interfere with the effect of saponin. 
Besides saponin is one major component in JL. Many studies have shown that 
saponin could reduce serum cholesterol level (Sidhu et aL, 1986; Harwood et al, 
1993; Morehouse et al., 1999). The hypolipidemic effect ofEL may therefore be due 
to the presence of saponin. 
Results of a preliminary test (data not shown) indicated that, E. and SEF did not 
affect the serum cholesterol and triglyceride levels in hyperlipidemic mice after 
administration for two weeks. Both E. and SEF reduced the serum cholesterol and 
triglyceride level in mice fed with a high-cholesterol emulsion and hyperlipidemic 
mice. The effects of JL or SEF in mice fed with a high-cholesterol emulsion were 
faster than that of hyperlipidemic mice. Therefore JL or SEF may have an efFect on 
gastrointestinal cholesterol absorption. 
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Both serum cholesterol and triglyceride levels in the streptozotocin-induced 
diabetic mice were reduced after administration o f H . and SEF. The elevated serum 
cholesterol and triglyceride levels in diabetic mice are due to insulin deficiency. 
Insulin can affect serum cholesterol level by increasing cholesterol absorption 
(Masako et aL, 1995) and serum triglyceride level by stimulating storage ofadipose 
tissue. Although the mechanism ofE> or SEF is not known, JL and SEF may have an 
effect on insulin secretion as mentioned in the discussion ofChapter 3. 
Serum cholesterol and triglyceride levels are reduced after consumption of 
green tea (Imai et aL, 1995). It may be due to the flavonoids present in green tea. 
Flavonids are polyphenolic compounds with a basic chemical structure of two 
aromatic rings joined by a three-carbon aliphatic chain. Several animal experiments 
have also demonstrated the effects of polyphenol in green tea in lowering serum 
cholesterol level O^luramatsu et al, 1986; Chan et aL, 1999). EL also contains 
polyphenols, which may contribute in reducing the serum cholesterol and 
triglycerides levels. 
Saponins form a heterogeneous group of triterpenes or steroid glycosides, which 
occur in hundreds of plant species (Oakenfull et al, 1990). Many of these are staple 
items of the human diet (Oakenfull et aI., 1981). Examples particularly rich in 
saponins are soya bean {Glycine maz) and n^vy beans {Phaseolus vulgaris). Isolated 
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saponins and food containing saponins have been shown to lower plasma cholesterol 
concentration in a number of animal species (Maiinow et aL, 1977). Although the 
mechanism of saponin in R. or SEF involved in reducing cholesterol is not known, 
the effect of other saponins in plants such as soya bean saponin can be used to 
deduce the mechanism of saponin in IL or SEF. 
There appear to be several possible mechanisms by which saponin affects 
cholesterol metabolism. The most obvious and of the longest standing is that, 
because saponin can form complexes with cholesterol in vitro, they can also form 
similar complexes with cholesterol in the gut lumen and thus directly inhibit 
absorption of cholesterol (Coulson et al., 1960; Jon et al., 1984). 
Another possible mechanism is that saponin interferes with the enterohepatic 
circulation of bile acids to affect cholesterol metabolism indirectly. Bile acids and 
their salts are relatively hydrophilic cholesterol derivatives that are synthesized in the 
liver. They pass through the bile duct into the small intestine where they promote 
lipid digestion and absorption by forming mixed micelles with fatty acids, 
monoglycerides and cholesterol. Lipid absorption occurs in the upper small intestine 
but the liberated bile acids are, for the most part, not absorbed until they reach the 
distal small intestine. Then they pass into the portal blood stream through an active 
transport process and then retum to the liver for reuse. The reabsorption ofbile acids 
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depends on the amount of liberated bile acids. Non-absorbable materials that bind 
bile acids make them pass on into the colon and eventually excreted in the faeces. 
The loss by faecel excretion can induce an increase in endogenous cholesterol 
synthesis resulting in reduction of serum cholesterol level to compensate for the loss 
0<fatalia etaL, 1985). 
Some saponins have recently been shown to form large mixed micelles with bile 
acids (Sidhu et aL, 1986). They can have molecular weights of several millions 
(Sidhu et al., 1986). It is because saponin and bile acids are both amphiphilic 
compounds, partly hydrophobic and partly hydrophilic. Jn aqueous solution they 
form small micelles with their hydrophobic triterpene or steroid groups stacking 
together. When the two types of compounds are mixed，their hydrophobic groups 
interleave with each other in their stacks. The stacks become greatly extended, 
incorporating many hundreds of molecules. The large stacks indeed block 
reabsorption ofbi le acids from the small intestine (Sidhu et al., 1986). 
Another possibility is that saponins may affect cholesterol metabolism by 
interacting with sterols in the brush border membranes of the intestinal mucosal cells 
(Johnson et al., 1986). Hemolytic saponins significantly increase the permeability of 
isolated intestine in vitro. Similar effects might occur in intact animals. It might thus 
affect nutrient adsorption. 
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Moreover the decrease in serum cholesterol concentration may also be 
associated with the enzyme acyl-CoA: cholesterol acyltransferase (ACAT). ACAT 
functions mainly to esterify cholesterol and store it as cholesterol ester. Thus it plays 
a key role in the intestinal absorption of cholesterol (Largis et al, 1989). Dietary 
cholesterol is esterified before it is assembled in chylomicrons and secreted into the 
lymphatic system. Therefore decrease in intestinal esterification of cholesterol by 
inhibiting ACAT can decrease serum cholesterol level. Fukuda et al. (1996) showed 
that an extract ofkudingcha can inhibit ACAT activity. 
The mechanism of saponin in reducing serum cholesterol level can also be used 
to explain its effect on serum triglyceride level. After administration in diet, bile salts 
can emulsify the triglycerides in the small intestine, forming mixed micelles for 
intestinal lipase degradation. Saponin which binds with bile acids can interfere 
micelle formation and reduce the effect of intestinal lipase resulting in reduced 
absorption of triglyceride. 
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EL is one of hollies in Trilex tea and is a kind ofKundingcha. SEF is one of the 
major components in JL. The acute and sub-chronic effects of JL and SEF were 
studied in mice. It was found that EL and SEF had no effect on serum AST and ALT 
activities in mice one day and two weeks after administration, indicating no 
hepatocyte damage after R. or SEF treatment. 
In the detoxification test, JL and SEF had no effect on MROD and EROD 
activities after administration for one day and two-weeks, indicating that DL and SEF 
did not affect some of the phase I enzymes. However JL induced liver GST activity 
except for the lowest dose (0.3gy^g). No GST induction effect could be found in mice 
treated with SEF in the two sets of experiments. Comparing the effects of R. and SEF 
on GST induction，it was revealed that the components o f I L for GST induction might 
not be related to its saponin fraction. Moreover GST is one of phase I I enzymes for 
removing xenobiotic metabolites. Therefore increased GST activity can enhance the 
process of detoxificiation. Therefore the effect of JL in detoxification can be partially 
reflected by GST induction. 
For studies on the hypoglycemic effect of JL and SEF, only the highest dose of 
JL (3g/kg) and SEF (lOOmg/kg) reduced the serum glucose level in the oral glucose 
tolerance test. However there is no effect on streptozotocin-induced diabetic mice 
after administration ofDL or SEF. It indicated that the acute hypoglycemic effect ofEL 
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and SEF might be related to gastrointestinal glucose absorption. Besides both R. and 
SEF reduced the serum glucose level. EL also contains about 20% saponin. The 
hypoglycemic effect o f E . may be related to the presence ofsaponin. Some saponins 
were found to inhibit active transport by increasing the general permeability of 
enterocytes in the gut (Johnson et al, 1986). This phenomenon ofsaponin may be one 
of the reasons that can be used to explain the effects oftt> and SEF on oral glucose 
tolerance test. The other reason might be related to interaction between saponin and 
the cell membrane. The interaction of saponin and the cell membrane may cause 
structural lesions，increasing the turnover rate of intestinal，mucosal cells and 
resulting in increased nutrient loss. 
Both JL and SEF reduced serum glucose level in streptozotocin-induced diabetic 
mice after administration for one month. It indicated that the chronic hypoglycemic 
effect of EL and SEF might not only be due to its effect on glucose absorption. 
According to the result of Glombitza et al (1994), saponin induced pancreatic cAMP 
level in diabetic animals after one-month administration. An elevated level of 
pancreatic cAMP may induce insulin secretion. It may be one of the reasons for the 
effectofELandSEF. 
In the studies on the hyperlipidemic effect of K. and SEF, only the high dose of 
n . (3g/kg) and SEF reduced serum level of cholesterol and triglycerides significantly. 
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It indicated that IL and SEF might affect cholesterol and triglycerides absorption. IL 
and SEF also reduced serum levels of cholesterol and triglycerides in hyperlipidemic 
mice. The hypolipidemic effect of IL and SEF might be related to the presence of 
saponin. Saponin can lower serum level of cholesterol and triglycerides in many 
different studies (Morehouse et al., 1999). It can provide some information for 
explaining the result of IL and SEF in hyperlipidemic mice. First of all, saponin may 
interact with cholesterol to fonn a large complex to prevent cholesterol absorption. 
Then saponin may also interact with bile acids to interfere with bile acid re-absorption 
and increase bile acid excretion. It results in increasing cholesterol utilization to 
compensate for the loss. The final possible mechanism for thehypolipidemic effect of 
saponin is that it may interact with the membrane of intestinal mucosal cells and result 
in a change in the permeability of membrane to prevent cholesterol absorption. 
IL and SEF also lowered the serum level of cholesterol and triglycerides in 
diabetic mice. The mechanism may also be related to the presence of saponin and can 
be explained by the above mechanisms. The hyperlipidemic effect in mice is due to 
insulin deficiency. Besides, as mentioned in Chapter 3, the hypolipidemic effect of IL 
and SEF may be related to the induction of insulin secretion. 
According to the above results, IL and SEF lowered serum levels of glucose, 
cholesterol and triglycerides but did not produce any liver cell damage. IL is rich in 
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saponins. Therefore the efFect of JL may be related to the presence of saponin. 
Besides DL also induced GST activity. However GST induction of JL may be related 
to the other components in EL. According to the above results，one beneficial effect of 
EL may be related to prevention of nutrient absorption. Administration of EL before a 
meal may reduce nutrient absorption and satiate the appetite simultaneously. 
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